Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04996732

Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Neoplasms Drug Therapy Radiotherapy Surgery Survival

Sex eligibility

All sexes

Study type

Observational

Primary location

Fudan University Shanghai Cancer Center

Shanghai, China

Location status: Recruiting

Location contact

Ying Zheng, Dr.

CONTACT

[email protected]

+8618121299522

About this study

This is a single-center continuous enrollment cohort study. The overall survival and disease-free survival of patients with malignant tumors in the target tumor hospital undergoing surgery, radiotherapy, chemotherapy, and immunotherapy were observed. Follow-up methods include medical records review, telephone call interview, and data linkage to the related provincial death certificate registries. This study will provide real world data-sets for researches on long-term survival and prognosis of cancer patients, and expend exploration on the cancer survival determinants both from clinical and social-economic prospective.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.

Exclusion criteria

  • Patients who have not been treated during hospitalization;
  • Patients with non-malignant tumors.

Treatment and study plan

hospitalization

Procedure

Including various treatments such as surgery, radiotherapy, chemotherapy and immunotherapy during hospitalization

Primary outcomes

  1. Overall survival

    Time frame: 15 years

    Death from any cause

Secondary outcomes

  1. Disease-free survival

    Time frame: 15 years

    the time from treatment to recurrence of cancer, second primary cancer or death

Study contacts

Contact information is provided by the study sponsor or research team.

Ying Zheng, Dr.

CONTACT

[email protected]

+8618121299522

Sponsors and collaborators

Lead sponsor

Fudan University

Other

Registry information

Official study title

Studies on Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Fudan University Shanghai Cancer Center Registry（FUCaRe）

Important dates

Study start
2008
Primary completion
2040
Study completion
2041
First posted
Aug 9, 2021
Registry last updated
Aug 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.